Hepatitis C among methadone maintenance treatment patients in Shanghai and Kunming, China
- PMID: 22138488
- PMCID: PMC3285118
- DOI: 10.1093/pubmed/fdr098
Hepatitis C among methadone maintenance treatment patients in Shanghai and Kunming, China
Abstract
Background: This study aims to: (1) document the prevalence of hepatitis C virus (HCV) among methadone maintenance treatment (MMT) patients in Kunming and Shanghai; (2) examine risk factors for HCV by comparing those who tested positive with those who were negative and (3) examine if HCV serostatus is related to attitudes toward MMT.
Methods: Using data collected from 306 patients admitted to MMT in 2009-2010 in Shanghai and Kunming, we compared HCV-positive and HCV-negative patients (based on clinical records) on their HCV knowledge and risk behaviors and attitudes toward MMT.
Results: The HCV seropositive rate was 53.3% (51.3% in Shanghai and 55.5% in Kunming) and a majority of patients did not know their serostatus. Patients scored on average fewer than 6 correct out of the 20 items in the HCV knowledge questionnaire. Recent injection use and length of opiate use were strong predictors of HCV status, while no differences were found between HCV-positive and HCV-negative individuals in sexual risks or HCV knowledge. Both groups expressed similar views toward MMT.
Conclusion: The high HCV prevalence and the general lack of knowledge about HCV infection, transmission and treatment suggest the need to provide HCV education and health promotion programs among patients in MMT.
Similar articles
-
Hepatitis C infection, related services, and barriers to HCV treatment among drug users in methadone maintenance treatment (MMT) clinics in Shanghai, China.Harm Reduct J. 2017 Nov 2;14(1):71. doi: 10.1186/s12954-017-0197-3. Harm Reduct J. 2017. PMID: 29096647 Free PMC article.
-
Hepatitis C seroconversion in methadone maintenance treatment programs in Wuhan, China.Addiction. 2015 May;110(5):796-802. doi: 10.1111/add.12836. Epub 2015 Jan 22. Addiction. 2015. PMID: 25529103 Free PMC article.
-
DOES IT WORK? -a randomized controlled trial to test the efficacy of HCV and HIV-related education on drug users in MMT, China.BMC Infect Dis. 2019 Sep 5;19(1):774. doi: 10.1186/s12879-019-4421-5. BMC Infect Dis. 2019. PMID: 31488064 Free PMC article. Clinical Trial.
-
Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment.Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S330-5. doi: 10.1086/427475. Clin Infect Dis. 2005. PMID: 15768343 Review.
-
Hepatitis C virus transmission dynamics in injection drug users.Subst Use Misuse. 1998 Apr;33(5):1197-212. doi: 10.3109/10826089809062214. Subst Use Misuse. 1998. PMID: 9596383 Review.
Cited by
-
The globalization of addiction research: capacity-building mechanisms and selected examples.Harv Rev Psychiatry. 2015 Mar-Apr;23(2):147-56. doi: 10.1097/HRP.0000000000000067. Harv Rev Psychiatry. 2015. PMID: 25747927 Free PMC article. Review.
-
Baseline HCV Antibody Prevalence and Risk Factors among Drug Users in China's National Methadone Maintenance Treatment Program.PLoS One. 2016 Feb 23;11(2):e0147922. doi: 10.1371/journal.pone.0147922. eCollection 2016. PLoS One. 2016. PMID: 26906025 Free PMC article.
-
Hepatitis C Knowledge and Self-Reported Testing Behavior in the General Population in China: Online Cross-Sectional Survey.JMIR Public Health Surveill. 2023 Dec 11;9:e39472. doi: 10.2196/39472. JMIR Public Health Surveill. 2023. PMID: 38079213 Free PMC article.
-
Hepatitis C infection, related services, and barriers to HCV treatment among drug users in methadone maintenance treatment (MMT) clinics in Shanghai, China.Harm Reduct J. 2017 Nov 2;14(1):71. doi: 10.1186/s12954-017-0197-3. Harm Reduct J. 2017. PMID: 29096647 Free PMC article.
-
A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan.Hepatol Int. 2015 Jul;9(3):378-90. doi: 10.1007/s12072-015-9629-x. Epub 2015 Jun 13. Hepatol Int. 2015. PMID: 26071238 Review.
References
-
- Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy. 2007;18(5):352–8. doi:10.1016/j.drugpo.2007.04.004. - DOI - PubMed
-
- Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5(9):558–67. doi:10.1016/S1473-3099(05)70216-4. - DOI - PubMed
-
- Xia X, Luo J, Bai J, et al. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis. Public Health. 2008;122(10):990–1003. doi:10.1016/j.puhe.2008.01.014. - DOI - PubMed
-
- World Health Organization (WHO) Geneva: WHO; Hepatitis C. Fact sheet No 164 www.who.int/inf-fs/en/fact164.html. (10 September 2010, date last accessed)
-
- Garter RJ, Lai S, Zhang J, et al. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol. 2004;33(1):182–8. doi:10.1093/ije/dyh019. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical